BI 207127

BI-207127 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for BI 207127, covering 2014-01-23 to 2016-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients [Phase 1]